Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

Fluvoxamine attenuates COVID-19 disease

May 19, 2022

Steven Lippmann, M.D. The coronavirus pandemic caused us some hard times – disruption, devastation, and death. Despite a recent rise in COVID-19 disease incidence, there is a general feeling that the illness is diminishing. There are countermeasures to mitigate its severity: several vaccines, monoclonal antibody therapies, and antiviral agents. Vaccines can induce some immunity, monoclonal […]

What? Botox injections can mitigate depressions?

May 17, 2022

Steven Lippmann, M.D.   “Botox”, or botulinum toxin, has long had popular cosmetic use at smoothing facial wrinkles.  It is also prescribed for pathologies, mostly of neuromuscular origins, like in pain syndromes and/or muscular spam cases. Many people like and benefit from the results. Researchers began noticing that injecting extracts from the bacterium Clostridium botulinum into […]

Suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors

May 12, 2022

Leo Sher, M.D. Our research report, “Decreased suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors: an open study” was published 10 years ago in the April 2012 issue of Psychiatry Research (1). We have examined clinical parameters before and after three months of open selective […]

Suicidal behavior in depressed older adolescents and young adults with or without comorbid alcohol use disorder

March 9, 2022

Leo Sher, M.D. Our research report, “Triggers for suicidal behavior in depressed older adolescents and young adults: do alcohol use disorders make a difference?” was published in the January-March 2007 issue of the International Journal of Adolescent Medicine and Health (1). In this study, we compared demographic and clinical characteristics, prevalence of interpersonal triggers and […]

Suicide mortality in the U.S. decreased from 2018 to 2020 after increasing since 2000

March 8, 2022

Leo Sher, M.D. The report, “Suicide mortality in the United States, 2000–2020” has recently been published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics (1). According to this report, suicide mortality in the U.S. increased from 2000 to 2018, then decreased from 2018 to 2020. Suicide deaths were identified […]

Thirty years of publications in the field of suicidology

March 2, 2022

Leo Sher, M.D. A research report, “Thirty years of publications in suicidology: A bibliometric analysis” has recently been published in Archives of Suicide Research (1). The authors performed a quantitative assessment of publications in suicidology between 1989 and 2018. Web of Science was used to identify publications on suicidal behavior from January 1, 1989 to […]

Osteoporosis drugs are associated with depression and anxiety

February 28, 2022

Leo Sher, M.D. A research paper, “Common osteoporosis drug associated with increased rates of depression and anxiety” has recently been published in Scientific Reports (1). Amongst the most common drug therapies for osteoporosis are bisphosphonates, including alendronate, zoledronate, ibandronate and risedronate. Other first-line options with a different molecular mechanism include denosumab and teriparatide. The author […]

Smoking, suicide risk, and the COVID-19 pandemic

February 15, 2022

Leo Sher, M.D. My commentary, “Smoking enhances suicide risk-a significant role in the COVID-19 pandemic?” has recently been published in the QJM: An International Journal of Medicine (1). A summary of my article is below: The COVID-19 outbreak has severely affected the whole world. Considerable evidence suggests that tobacco smoking is associated with increased severity […]

Samuel Johnson quote

January 13, 2022

Nothing will ever be attempted if all possible objections must be first overcome. – Samuel Johnson (1709 -1784)

The World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Men’s Mental Health – January 2022 update

January 12, 2022

Leo Sher, M.D. The World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Men’s Mental Health was founded in 2013. Currently, the WFSBP Task Force on Men’s Mental Health consists of scholars from many countries in different parts of the world. The updated list of the Task Force Members is below: Founding Chair: […]

1 2 3 4 ›»

Editorials

  • Fluvoxamine attenuates COVID-19 disease
  • What? Botox injections can mitigate depressions?
  • Smoking, suicide risk, and the COVID-19 pandemic
  • Omicron spread and oral antiviral pills are big news. The advent of nirmatrelvir and ritonavir: called Paxlovid

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Thirty years of publications in the field of suicidology
  • Osteoporosis drugs are associated with depression and anxiety
  • A study of relation between the use of cannabis in adolescence and self-harm or suicide
  • Senior WISE intervention: Gender differences in bodily pain and trait anxiety

Latest News

  • Suicide mortality in the U.S. decreased from 2018 to 2020 after increasing since 2000
  • The World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Men’s Mental Health – January 2022 update
  • The Nobel Prize in Physiology or Medicine 2021
  • 2021 National Veteran Suicide Prevention Annual Report

Interviews with eminent psychiatrists

  • Interview with Professor Shih-Ku Lin
  • Interview with Professor Masahito Fushimi
  • Interview with Professor Maurizio Pompili
  • Interview with Professor Marco Sarchiapone

Ten Years Ago

  • Suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors
  • Treatment of suicide attempters with bipolar disorder: a randomized clinical trial
  • Posttraumatic stress disorder and the Neuroevolutionary Time-depth Principle
  • The role of endogenous opioids and monoamine neurotransmitters in non-suicidal self-injury

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2022 AVCalc LLC. All rights reserved worldwide.